REG - Geiger Counter Ltd Geiger Counter - GCS - Resignation of Portfolio Managers

Geiger CounterAnnouncement

09/03/2026 09:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260309:nRSI8614Va&default-theme=true

RNS Number : 8614V  Geiger Counter Ltd  09 March 2026

THIS ANNOUNCEMENT CONTAINS INFORMATION THAT IS INSIDE INFORMATION FOR THE
PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) No. 5985/2014 WHICH
IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS
AMENDED

 
 

 
Geiger Counter Limited (or the "Company")

09 March 2026

Portfolio Management arrangements

 

The Board of the Company has been notified that the Company's two co-portfolio
managers, Keith Watson and Rob Crayfourd (together the "Co-Managers"), have
resigned from Manulife CQS Investment Management ("Manulife CQS").

The Co-Managers are serving their  three ‑month notice periods at Manulife
CQS. The Board does not expect any immediate disruption to its investment
process or operations.

The Board is considering its options regarding future portfolio management
arrangements and will make a further announcement in due course.

 

Enquiries

 

 Manulife  CQS Investment Management      Craig Cleland                             T: +44 (0) 20 7201 5368]
 Cavendish Capital Markets Limited       Tunga Chigovanyika                         T: +44 (0) 20 7397 1915

                                          (Corporate Finance)
                                         Daniel Balabanoff / Pauline Tribe (Sales)  T: +44 (0) 20 7220 0500
 Summit Fund Services Jersey Limited     Christopher Foulds                         T :+44 (0) 1534 825 259

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUKVWRNWUORRR



            Copyright 2019 Regulatory News Service, all rights reserved